Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT

Clin Nucl Med. 2023 Aug 1;48(8):743-745. doi: 10.1097/RLU.0000000000004719. Epub 2023 May 23.

Abstract

Mixed neuroendocrine carcinoma-acinar carcinoma is an uncommon histological type of neuroendocrine prostate cancer. It has been rarely reported in de novo prostate malignancies. In this case, we present 68 Ga-PSMA (prostate-specific membrane antigen), 68 Ga-FAPI, and 18 F-FDG PET/CT findings in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in different metastatic sites on 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT. This case demonstrates that the multitracer PET/CT strategy may be used for the noninvasive detection of the intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.

MeSH terms

  • Carcinoma, Acinar Cell*
  • Carcinoma, Neuroendocrine* / diagnostic imaging
  • Fluorodeoxyglucose F18
  • Gallium Radioisotopes
  • Humans
  • Male
  • Positron Emission Tomography Computed Tomography
  • Prostate / pathology
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology
  • Radiopharmaceuticals

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals
  • Gallium-68
  • gallium 68 PSMA-11
  • Gallium Radioisotopes